A detailed history of Bank Of America Corp transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,714,620 shares of TVTX stock, worth $31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,714,620
Previous 1,878,954 8.75%
Holding current value
$31 Million
Previous $15.4 Million 55.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.89 - $15.21 $1.3 Million - $2.5 Million
-164,334 Reduced 8.75%
1,714,620 $24 Million
Q2 2024

Aug 14, 2024

BUY
$5.26 - $8.28 $890,628 - $1.4 Million
169,321 Added 9.9%
1,878,954 $15.4 Million
Q1 2024

May 15, 2024

BUY
$7.18 - $9.82 $633,031 - $865,790
88,166 Added 5.44%
1,709,633 $13.2 Million
Q4 2023

Feb 14, 2024

BUY
$5.44 - $9.5 $1.48 Million - $2.58 Million
271,964 Added 20.15%
1,621,467 $14.6 Million
Q2 2023

Aug 14, 2023

BUY
$15.3 - $22.61 $8.13 Million - $12 Million
531,678 Added 65.01%
1,349,503 $20.7 Million
Q1 2023

May 12, 2023

BUY
$17.82 - $22.89 $4.67 Million - $5.99 Million
261,887 Added 47.11%
817,825 $18.4 Million
Q4 2022

Feb 10, 2023

BUY
$18.47 - $26.14 $2.26 Million - $3.2 Million
122,520 Added 28.27%
555,938 $11.7 Million
Q3 2022

Nov 14, 2022

SELL
$22.91 - $28.63 $2.08 Million - $2.6 Million
-90,879 Reduced 17.33%
433,418 $10.7 Million
Q2 2022

Aug 12, 2022

SELL
$20.94 - $30.01 $1.56 Million - $2.24 Million
-74,580 Reduced 12.45%
524,297 $12.7 Million
Q1 2022

May 16, 2022

BUY
$23.61 - $30.6 $2.07 Million - $2.68 Million
87,507 Added 17.11%
598,877 $15.4 Million
Q4 2021

Feb 08, 2022

SELL
$24.34 - $31.17 $10.8 Million - $13.8 Million
-444,060 Reduced 46.48%
511,370 $15.9 Million
Q3 2021

Nov 15, 2021

SELL
$12.98 - $25.03 $9.31 Million - $17.9 Million
-717,055 Reduced 42.87%
955,430 $23.2 Million
Q2 2021

Sep 13, 2021

BUY
$14.11 - $26.4 $23.6 Million - $44.2 Million
1,672,485 New
1,672,485 $24.4 Million

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.16B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.